Create a free account

B3 · BRL

PNVL3

Dimed S.A. Distribuidora de Medicamentos

R$12.70+1.93% (R$0.24)
Day's range
R$12.27 – R$12.70
Day's volume
R$7.5M
52-week range
R$9.01 – R$16.57

Follow PNVL3 in the Fuolio

See how PNVL3 weighs in your net worth, what it has paid you and how far it is from your target allocation.

Create a free account

PNVL3 in numbers

Market cap
R$1.9B
P/E
13.87
P/B
1.45
Dividend yield (12m)
3.91%
Net debt/EBITDA
2.95

The 12-month dividend yield of PNVL3 is 3.91%, above its 5-year average of 1.89%.

PNVL3 price history

10/01/202509/30/2026
Compare with

PNVL3 risk and return

Monthly closes adjusted for splits and distributions.

Metric12 months36 months60 months
Return+32.46%+18.41%-3.38%
Volatility (annualized)38.50%30.19%31.21%
Largest drawdown-31.02%-36.56%-39.97%
Positive months7/1216/3628/60

How much did investing in PNVL3 return?

R$1,000.00 invested on 09/01/2021 would be worth R$966.18 today.

Value today in PNVL3
R$966.18
Return over the period
-3.38%
Return per year
-0.69%
In the Ibovespa
R$1,657.66

With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.

PNVL3 fundamentals

Valuation

  • P/E
    13.87
  • P/B
    1.45
  • EV/EBITDA
    6.60
  • EV/EBIT
    12.29
  • EV/Revenue
    0.59
  • P/EBIT
    6.80
  • P/S
    0.32
  • P/OCF
    4.54
  • P/FCF
    8.72
  • Earnings yield
    8.14%
  • PEG ratio
    0.79
  • Earnings per share
    R$0.92
  • Book value per share
    R$8.76

Debt

  • Net debt
    R$1.5B
  • Net debt/EBITDA
    2.95
  • Net debt/Equity
    1.17
  • Debt/Equity
    1.40
  • Current ratio
    1.75
  • Quick ratio
    0.78
  • Cash ratio
    0.24

Efficiency

  • Gross margin
    32.32%
  • EBITDA margin
    8.87%
  • Operating margin
    4.76%
  • Net margin
    2.33%
  • Asset turnover
    1.59

Profitability

  • ROE
    10.45%
  • ROA
    3.71%
  • ROIC
    8.39%
  • Payout
    54.23%

Growth

  • Revenue CAGR (5 years)
    14.24%
  • Earnings CAGR (5 years)
    11.80%
  • Revenue growth (year)
    11.53%
  • Earnings growth (year)
    18.10%
  • Revenue growth (quarter)
    14.42%
  • Earnings growth (quarter)
    17.26%

What is PNVL3's fair price?

Two classic value formulas, with today's numbers. The current price is R$12.70.

Graham's fair price
R$13.43
5.75% above the price

√(22.50 × R$0.92 × R$8.76)

Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.

Bazin's ceiling price
R$3.48
72.58% below the price

R$0.21 (5-year average) ÷ 6%

Décio Bazin only bought stocks yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years over 6%.

Graham ignores growth and debt; Bazin assumes past distributions repeat. They are references to compare, not a buy recommendation.

PNVL3's indicators by year

Multiples at each year's closing price; margins and returns from that year's statements.

Indicator20252024202320222021202020192018
P/E14.4712.5421.6217.6625.3558.811,039.6418.67
P/B1.411.071.711.381.923.27152.243.02
EV/EBITDA6.806.518.647.6910.1317.65373.5211.56
Dividend yield1.68%2.92%1.66%1.86%1.31%14.61%23.19%37.69%
Earnings per shareR$0.83R$0.70R$0.62R$0.57R$0.53R$0.37R$0.57R$16.60
Book value per shareR$8.52R$8.21R$7.80R$7.37R$6.96R$6.67R$3.87R$102.73
ROE9.72%8.55%7.92%7.79%7.59%5.56%14.64%16.16%
ROIC7.81%7.18%7.14%6.67%5.83%6.52%9.94%13.30%
Gross margin32.37%31.79%30.87%31.14%30.65%29.22%29.69%29.44%
EBITDA margin8.84%8.20%8.22%8.07%8.04%7.45%7.90%5.75%
Net margin2.26%2.13%2.08%2.16%2.46%1.99%2.82%3.08%
Net debt/EBITDA3.103.253.162.952.371.922.881.54

PNVL3's financial statements

Line202520242023202220212020
Net revenueR$5.5BR$4.9BR$4.5BR$4BR$3.2BR$2.8B
Cost of revenue-R$3.7B-R$3.4B-R$3.1B-R$2.7B-R$2.2B-R$2B
Gross profitR$1.8BR$1.6BR$1.4BR$1.2BR$988.6MR$823.7M
EBITDAR$487.2MR$405.4MR$366.7MR$321.9MR$259.5MR$209.9M
EBITR$254.7MR$195.3MR$166.6MR$137.3MR$101.5MR$92.2M
Financial result-R$109.2M-R$82.7M-R$75M-R$58.9M-R$18.3M-R$38.9M
Income before taxR$145.5MR$112.6MR$91.6MR$78.4MR$83.2MR$53.3M
Income tax-R$20.9M-R$7.1MR$1.3MR$7.9M-R$3.8MR$2.8M
Net incomeR$124.6MR$105.5MR$92.9MR$86.3MR$79.4MR$56.2M

Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.

PNVL3 against its sector

The same indicators for the company's other shares and the sector's largest stocks.

StockP/EP/BDividend yield (12m)ROEMarket cap
PNVL3Distribuidora De Medicamentos13.871.453.91%10.45%R$1.9B
VBBR3VIBRA ENERGIA S.A.8.811.895.32%21.49%R$44.5B
UGPA3ULTRAPAR PARTICIPACOES S.A.12.152.345.31%19.25%R$42B
RADL3RAIA DROGASIL S.A.23.984.422.42%18.41%R$32.2B
ASAI3SENDAS DISTRIBUIDORA S.A.15.342.330.95%15.21%R$14.8B
GMAT3GRUPO MATEUS S.A.7.201.050.98%14.52%R$11.7B
LREN3LOJAS RENNER S.A.7.821.137.93%14.41%R$11.7B

Does PNVL3 pay dividends?

Announced payments
TypeLast day to ownPaymentPer share
Interest on equity06/26/202603/31/2027R$0.02
Interest on equity03/26/202603/31/2027R$0.03
Interest on equity06/26/202604/30/2027R$0.02
Interest on equity03/26/202604/30/2027R$0.03
Interest on equity01/15/202604/30/2027R$0.05
Interest on equity06/26/202605/31/2027R$0.02
Interest on equity03/26/202605/31/2027R$0.03
Interest on equity01/15/202605/31/2027R$0.05
Interest on equity06/26/202608/31/2027R$0.06
Interest on equity01/15/202608/31/2027R$0.05
Interest on equity09/24/202603/31/2028R$0.04
Interest on equity09/24/202604/28/2028R$0.04
Interest on equity09/24/202605/31/2028R$0.04

Dividend yield per year

  • 28.18%2017
  • 37.69%2018
  • 23.19%2019
  • 14.61%2020
  • 1.31%2021
  • 1.86%2022
  • 1.66%2023
  • 2.92%2024
  • 1.68%2025
  • 2.15%2026
Payment history
TypeLast day to ownPaymentPer share
Interest on equity07/03/202508/31/2026R$0.05
Interest on equity10/03/202505/29/2026R$0.02
Interest on equity07/03/202505/29/2026R$0.04
Interest on equity03/26/202504/30/2026R$0.09
Interest on equity12/16/202403/31/2026R$0.08
Interest on equity12/16/202405/30/2025R$0.01
Interest on equity10/02/202405/30/2025R$0.06
Interest on equity12/16/202404/30/2025R$0.01
Interest on equity10/02/202404/30/2025R$0.03
Interest on equity06/26/202404/30/2025R$0.03
Interest on equity12/16/202403/31/2025R$0.01
Interest on equity06/26/202403/31/2025R$0.04
See all 101 distributions
Earlier distributions
TypeLast day to ownPaymentPer share
Interest on equity04/05/202403/31/2025R$0.02
Interest on equity04/05/202408/30/2024R$0.06
Interest on equity12/22/202308/30/2024R$0.01
Interest on equity12/22/202305/31/2024R$0.06
Interest on equity12/22/202304/30/2024R$0.06
Interest on equity11/30/202303/29/2024R$0.08
Interest on equity08/22/202308/31/2023R$0.05
Interest on equity12/26/202205/31/2023R$0.06
Interest on equity12/26/202204/28/2023R$0.06
Interest on equity12/26/202203/31/2023R$0.06
Interest on equity08/22/202208/31/2022R$0.05
Interest on equity12/27/202105/31/2022R$0.04
Interest on equity12/27/202104/30/2022R$0.04
Interest on equity12/27/202103/31/2022R$0.04
Interest on equity08/20/202108/31/2021R$0.04
Interest on equity12/30/202005/31/2021R$0.05
Interest on equity12/30/202004/30/2021R$0.05
Interest on equity12/30/202003/31/2021R$0.02
Interest on equity10/30/202003/31/2021R$0.02
Interest on equity12/26/201905/29/2020R$1.04
Interest on equity12/26/201904/30/2020R$1.04
Interest on equity10/02/201903/31/2020R$1.10
Interest on equity06/24/201910/31/2019R$0.62
Interest on equity06/24/201909/30/2019R$0.62
Interest on equity06/24/201908/30/2019R$0.62
Interest on equity12/20/201805/31/2019R$0.90
Interest on equity12/20/201804/30/2019R$0.90
Interest on equity12/20/201803/29/2019R$0.90
Interest on equity08/23/201810/31/2018R$0.56
Interest on equity08/23/201809/28/2018R$0.56
Interest on equity08/23/201808/31/2018R$0.56
Interest on equity12/28/201705/31/2018R$0.74
Interest on equity12/28/201704/30/2018R$0.74
Interest on equity12/28/201703/30/2018R$0.74
Interest on equity08/16/201710/31/2017R$0.53
Interest on equity08/16/201709/29/2017R$0.53
Interest on equity08/16/201708/31/2017R$0.53
Interest on equity12/28/201605/31/2017R$0.72
Interest on equity12/28/201604/28/2017R$0.72
Interest on equity12/28/201603/31/2017R$0.72
Interest on equity08/19/201610/31/2016R$0.47
Interest on equity08/19/201609/30/2016R$0.47
Interest on equity08/19/201608/31/2016R$0.47
Interest on equity08/18/201510/29/2015R$0.36
Dividend04/28/201505/28/2015R$0.18
Interest on equity08/12/201410/30/2014R$0.36
Dividend04/29/201405/29/2014R$0.36
Dividend04/26/201305/31/2013R$0.25
Interest on equity08/09/201108/31/2011R$0.87
Interest on equity08/10/201008/31/2010R$0.76
Interest on equity12/21/200903/31/2010R$1.08
Interest on equity08/10/200908/31/2009R$0.73
Interest on equity12/23/200803/31/2009R$0.51
Interest on equity08/11/200808/29/2008R$0.43
Interest on equity12/20/200703/31/2008R$0.51
Interest on equity08/08/200708/31/2007R$0.43
Interest on equity12/20/200603/30/2007R$0.51
Interest on equity08/08/200608/31/2006R$0.42
Interest on equity12/21/200503/29/2006R$0.49
Interest on equity08/02/200508/31/2005R$0.36
Interest on equity12/23/200403/30/2005R$0.54
Interest on equity07/19/200408/12/2004R$0.29
Interest on equity12/30/200303/18/2004R$0.46
Interest on equity07/23/200308/13/2003R$0.37
Interest on equity12/27/200203/07/2003R$0.37
Interest on equity08/01/200208/21/2002R$0.24
Interest on equity12/26/200103/05/2002R$0.33
Interest on equity07/17/200108/03/2001R$0.24
Dividend02/09/200103/05/2001R$0.08
Interest on equity12/27/200003/05/2001R$0.14
Interest on equity12/22/199904/06/2000R$0.12
Interest on equity07/27/199908/19/1999R$0.32
Interest on equity12/21/2015—R$0.65
Interest on equity12/19/2014—R$0.51
Interest on equity12/20/2013—R$0.72
Interest on equity08/09/2013—R$0.54
Interest on equity12/20/2012—R$0.69
Interest on equity08/10/2012—R$0.54
Interest on equity12/21/2011—R$0.67
Interest on equity12/21/2010—R$0.59
Interest on equity03/15/1999—R$0.07
Interest on equity12/29/1998—R$0.20
Interest on equity08/11/1998—R$0.30
Interest on equity12/30/1997—R$0.33
Interest on equity08/11/1997—R$0.38
Dividend02/13/1997—R$0.45
Dividend08/06/1996—R$0.30
Dividend01/31/1996—R$0.24
Dividend01/31/1996—R$0.15
Splits, reverse splits and bonus shares
EventLast day to ownRatio
Split03/20/202030 for 1
Bonus shares04/02/199628.57% in shares
Reverse split03/22/19951 for 1000

About Distribuidora De Medicamentos

Sector
Consumo Não Cíclico
Segment
Medicamentos e Outros Produtos
Listing segment
Novo Mercado
Tag along
100.00%
Free float
54.80%
Shares issued
150.38M common
Average daily trading
R$9.3M
Listed since
08/03/1984
CNPJ
92.665.611/0001-77

Dimed S.A. Distribuidora de Medicamentos, operando sob a marca Panvel, é uma empresa brasileira especializada em distribuição e varejo de medicamentos e produtos de saúde. A companhia opera uma rede de farmácias com presença em múltiplos estados brasileiros, oferecendo medicamentos, produtos de higiene, beleza e bem-estar. Panvel atua como distribuidora de medicamentos para farmácias e como varejista direto ao consumidor através de suas lojas físicas e plataforma de e-commerce. A empresa investe em tecnologia, logística e atendimento ao cliente para manter sua posição como uma das principais redes de farmácias do Brasil.

Investor website
ShareholdersAs of 12/31/2026, from the Formulário de Referência filed with the CVM.
ShareholderCommonPreferredTotal
JULIO RICARDO ANDRIGHETTO MOTTINControlling9.31%0.00%9.31%
SPX GESTÃO DE RECURSOS LTDA6.22%0.00%6.22%
ROBERTO LUIZ WEBERControlling4.10%0.00%4.10%
GERALDO OTTO WEBERControlling3.93%0.00%3.93%
DENIS PIZZATOControlling3.88%0.00%3.88%
MARTHA WEBER LUCEControlling3.85%0.00%3.85%
REGIS PIZZATOControlling3.50%0.00%3.50%
ELISABETH WEBER TAYLORControlling3.24%0.00%3.24%
NELSON DE ALVARENGA MARIANO DA ROCHAControlling2.39%0.00%2.39%
NADJA PIZZATOControlling1.80%0.00%1.80%
JOSE E P ANNONIControlling1.72%0.00%1.72%
ANA LUIZA MARIANO DA ROCHA MOTTINControlling1.56%0.00%1.56%
SYLVIA WAHRLICHControlling1.08%0.00%1.08%
JULIO RICARDO MOTTIN NETOControlling0.73%0.00%0.73%
RUDOLFO JOSE MUSSNICHControlling0.64%0.00%0.64%
FRANCISCO TOSTES MOTTIN0.52%0.00%0.52%
JULIA MOTTIN KUHLControlling0.50%0.00%0.50%
RAFAEL TOSTES MOTTIN0.41%0.00%0.41%
MIGUEL TOSTES MOTTIN0.37%0.00%0.37%
CARLOS ALBERTO DE FREITAS LIMAControlling0.21%0.00%0.21%
RAFAELLA POLESE WEBERControlling0.16%0.00%0.16%
ANTÔNIO CARLOS TOCCHETTO NAPPControlling0.15%0.00%0.15%
GABRIELA WEBER LUCEControlling0.15%0.00%0.15%
GUILHERME WEBER LUCEControlling0.14%0.00%0.14%
LUCAS WEBERControlling0.14%0.00%0.14%
PATRÍCIA WEBERControlling0.14%0.00%0.14%
MELISSA POLESE SCHNEIDERControlling0.14%0.00%0.14%
VIVIAN VIEIRA ALBRECHTControlling0.13%0.00%0.13%
NELSON DE CASTRO PERRONEControlling0.09%0.00%0.09%
PAULO ROBERTO BAGGIOControlling0.09%0.00%0.09%
MARIANA MARIANO DA ROCHA MOTTINControlling0.08%0.00%0.08%
GABRIELA ZUBARAN DE AZEVEDO PIZZATOControlling0.07%0.00%0.07%
MARCELA DE AZEVEDO PIZZATOControlling0.07%0.00%0.07%
ADRIANA MOTTIN VELLINHOControlling0.07%0.00%0.07%
LUCIA TOSTES MOTTIN0.07%0.00%0.07%
IVETE POLESE WEBERControlling0.02%0.00%0.02%
JOSÉ F A PIZZATO ANNONIControlling0.01%0.00%0.01%
Outros47.47%0.00%47.47%
Ações Tesouraria0.89%0.00%0.89%

Questions about PNVL3

How much is PNVL3 today?

PNVL3 is at R$12.70 (1.93% on the day), last traded on 10/01/2026.

How much did PNVL3 pay in dividends in 2025?

PNVL3 paid R$0.20 per share in 2025, a dividend yield of 1.68%.

When is the next PNVL3 dividend?

The next announced payment is R$0.02 per share on 03/31/2027.

What are the P/E and P/B of PNVL3?

PNVL3 trades at a P/E of 13.87 and a P/B of 1.45.

How much did PNVL3 return in 12 months?

PNVL3 returned 32.46% in 12 months, with annualized volatility of 38.50% and a largest drawdown of -31.02%.

What sector is PNVL3 in?

Distribuidora De Medicamentos is in the Consumo Não Cíclico sector, Medicamentos e Outros Produtos segment.